The Global Research Summit, the series of webinars on dementia research, is back

After the success of the first edition, Ace Alzheimer Center Barcelona once again organizes the Global Research Summit cycle of scientific conferences during June and September with the aim of maintaining scientific discussion and sharing the latest advances in research of neurodegenerative diseases.

“Global Research Summit was born in 2021 out of the need to continue learning constantly even in times of pandemic. After the success we obtained and thanks to the positive comments from the attendees of the last edition, we have decided to establish this cycle of conferences with a biannual periodicity so that it is a valid meeting point for scientists who are dedicated to investigating neurodegenerative diseases” points out Mercè Boada, co-founder and medical director of Ace Alzheimer Center Barcelona.

Renowned researchers will participate in the Global Research Summit 2023

The second Global Research Summit will take place in the same format as its first edition. Each of the three scheduled webinars will feature presentations by two renowned researchers in the field of neuroscience and, later, attendees will be able to question the speakers in a Q&A session.

The first session, which will be held on June 7, will deal with the latest research advances in dementia genetics. It will be led by Dr. Victoria Fernández, from the Washington University School of Medicine at St.Louis, and will include presentations by Dr. Alison Goate, from the Icahn School of Medicine at Mount Sinai; and Dr. Jean Charles Lambert, from the University of Lille.

For Agustín Ruiz, research director of Ace Alzheimer Center Barcelona, “Global Research Summit obeys the restless spirit of our organization. We open scientific knowledge to everyone with the aim of enriching professionals in the field of dementia with the latest research developments”.

Registration is open at

You might also like

The webinar “Molecular Biomarkers of Neurodegeneration” stands out for the high participation of attendees

More than 165 attendees of 18 different nationalities gathered to hear the latest news on molecular biomarkers in neurodegenerative diseases